Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).

Methods of Documentation II: POMR

Methods of Documentation II: POMR

The Problem-Oriented Medical Record (POMR) revolutionized medical record-keeping by introducing a systematic approach focusing on the patient's problems rather than merely listing symptoms. Dr. Lawrence Weed's introduction of this method in the 1960s marked a significant advancement in medical documentation. The POMR framework consists of four key components: the database, problem list, plan of care, and progress notes.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Bone morphogenic protein 9 is a novel thermogenic hepatokine secreted in response to cold exposure.

Metabolism: clinical and experimental·2022

Same author

Activin A/BMP2 Chimera (AB204) Exhibits Better Spinal Bone Fusion Properties than rhBMP2.

Journal of Korean Neurosurgical Society·2018

Same author

The Cardiovascular Effect of Single Injection and Toxicologic Effects of Repetitive 2-Week Intravenous Administration of Activin A/BMP-2 Chimera in Beagle Dog.

Cardiovascular toxicology·2017

Same author

Crystal structure of the EnvZ periplasmic domain with CHAPS.

FEBS letters·2017

Same author

Bone morphogenetic protein-9 is a potent growth inhibitor of hepatocellular carcinoma and reduces the liver cancer stem cells population.

Oncotarget·2016

Same author

S-Nitrosylation Induces Structural and Dynamical Changes in a Rhodanese Family Protein.

Journal of molecular biology·2016

Search research articles

Related Experiment Video

Updated: May 28, 2026

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Published on: March 20, 2021

BMPs and their clinical potentials.

Meejung Kim¹, Senyon Choe

¹Joint Center for Biosciences at Lee Gil Ya Cancer and Diabetes Research Institute, Gachon University of Medicine and Science, IncheonKorea.

|October 27, 2011

Summary

Bone morphogenetic proteins (BMPs) show promise beyond bone repair, offering therapeutic potential for metabolic, vascular, and cancer diseases. Emerging strategies include engineered BMPs and cell therapies for broader clinical applications.

Area of Science:

Biochemistry and Molecular Biology
Cell Biology
Medical Research

Background:

Bone morphogenetic proteins (BMPs) are crucial signaling molecules with established roles in skeletal development and repair.
Approved BMPs like BMP-2 and BMP-7 are clinically utilized for bone fractures and spinal fusions.
The therapeutic scope of BMP signaling extends beyond skeletal applications, indicating broader disease relevance.

Purpose of the Study:

To review the emerging clinical potentials of BMP signaling in non-skeletal diseases.
To explore advanced therapeutic tools such as engineered BMPs and ex vivo-conditioned cell therapies.
To provide insights into the application of BMPs in metabolic diseases, vascular diseases, and cancer.

Main Methods:

Literature review of studies on BMP signaling in various diseases.

More Related Videos

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications

Published on: April 28, 2015

Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System

Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System

Published on: April 23, 2021

Related Experiment Videos

Last Updated: May 28, 2026

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Published on: March 20, 2021

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications

Published on: April 28, 2015

Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System

Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System

Published on: April 23, 2021

Analysis of clinical applications and emerging therapeutic strategies involving BMPs.

Focus on next-generation tools like engineered BMPs and cell-based therapies.

Main Results:

BMPs are validated therapeutic targets for numerous clinical disorders.
Clinical applications of BMPs are expanding beyond orthopedic and spinal surgeries.
Engineered BMPs and cell therapies represent promising avenues for novel treatments.

Conclusions:

BMP signaling holds significant therapeutic potential for metabolic, vascular, and oncological conditions.
Advanced BMP-based therapies are being developed for a wider range of diseases.
Further research into BMPs can unlock novel treatment strategies for complex diseases.